$83 after marketing $70 to $78, and 980 million shares instead of 825. That tells you everything about the demand. The part I keep thinking about is the tension in the post, a lab built on safety promises now answering to a ticker every morning. That is a hard pair to hold together.
You are viewing a single comment's thread from: